Lake Street Capital Reiterates "Hold" Rating for LENSAR (NASDAQ:LNSR)

LENSAR (NASDAQ:LNSR - Get Free Report)'s stock had its "hold" rating restated by research analysts at Lake Street Capital in a research report issued on Monday, MarketBeat.com reports. They currently have a $15.00 price objective on the stock, down from their previous price objective of $16.00. Lake Street Capital's price target suggests a potential upside of 5.97% from the stock's current price.

LENSAR Price Performance

LNSR traded up $0.02 during trading hours on Monday, hitting $14.16. 73,373 shares of the stock were exchanged, compared to its average volume of 60,087. LENSAR has a 12 month low of $2.67 and a 12 month high of $17.31. The stock has a 50-day simple moving average of $11.93 and a 200-day simple moving average of $8.40. The stock has a market cap of $166.87 million, a price-to-earnings ratio of -9.69 and a beta of 0.62.

LENSAR (NASDAQ:LNSR - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing the consensus estimate of ($0.21) by ($1.40). LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The firm had revenue of $16.73 million for the quarter, compared to the consensus estimate of $14.95 million.

Institutional Trading of LENSAR

A number of large investors have recently added to or reduced their stakes in the business. Evernest Financial Advisors LLC acquired a new stake in shares of LENSAR during the 4th quarter valued at $174,000. Bailard Inc. acquired a new stake in shares of LENSAR during the fourth quarter worth $181,000. Atria Investments Inc lifted its holdings in shares of LENSAR by 28.2% during the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock valued at $233,000 after purchasing an additional 5,729 shares during the last quarter. Essex Investment Management Co. LLC lifted its holdings in shares of LENSAR by 18.3% during the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after purchasing an additional 6,184 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of LENSAR by 3.5% in the 3rd quarter. Geode Capital Management LLC now owns 100,431 shares of the company's stock valued at $460,000 after purchasing an additional 3,423 shares during the period. 40.15% of the stock is currently owned by institutional investors.

Remove Ads

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.